Leprosy pathophysiology: Difference between revisions

	Leprosy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Leprosy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Leprosy pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Leprosy pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Leprosy pathophysiology
CDC on Leprosy pathophysiology
Leprosy pathophysiology in the news
Blogs on Leprosy pathophysiology
Directions to Hospitals Treating Leprosy
Risk calculators and risk factors for Leprosy pathophysiology

Revision as of 23:41, 6 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 4: / Line 4: @@
 ==Overview==
-Worldwide, 1-2 million persons are permanently disabled as a result of Hansen's disease. However, persons receiving [[antibiotic treatment]] or having completed treatment are considered free of active infection.  Although the mode of [[transmission]] of Hansen's disease remains uncertain, most investigators think that [[M. leprae]] is usually spread from person to person in [[respiratory]] droplets.
+==Pathogenesis==
+==Genetics==
+==Associated Conditions==
+==Gross Pathology==
+==Microscopic Pathology==
 ==Pathophysiology==